Literature DB >> 12433736

Vitamin D receptor polymorphism and breast cancer risk.

Polly A Newcomb1, Han Kim, Amy Trentham-Dietz, Fredrico Farin, David Hunter, Kathleen M Egan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433736

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  6 in total

1.  TaqI polymorphism of VDR gene contributes to breast cancer risk.

Authors:  Hua Wang; Wenjian Wang; Dongjie Yang; Shenming Wang
Journal:  Tumour Biol       Date:  2013-08-01

2.  Circulating 25-Hydroxy Vitamin D Relative to Vitamin D Receptor Polymorphism after Vitamin D3 Supplementation in Breast Cancer Women: A Randomized, Double-Blind Controlled Clinical Trial

Authors:  Houra Mohseni; Seyed Ahmad Hosseini; Reza Amani; Alireza Ekrami; Ahmad Ahmadzadeh; Seyed Mahmoud Latifi
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

3.  Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial.

Authors:  Houra Mohseni; Reza Amani; Seyed Ahmad Hosseini; Alireza Ekrami; Ahmad Ahmadzadeh; Seyed Mahmoud Latifi
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

4.  Hormonal and genetic risk factors for breast cancer in a subset of the Karachi population.

Authors:  Fouzia Shaikh; Mohiuddin Alamgir; Sehrish Ahmed
Journal:  J Taibah Univ Med Sci       Date:  2022-02-01

5.  Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Authors:  Katherine D Crew
Journal:  ISRN Oncol       Date:  2013-02-26

6.  Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

Authors:  Sascha Abbas; Alexandra Nieters; Jakob Linseisen; Tracy Slanger; Silke Kropp; Elke Jonny Mutschelknauss; Dieter Flesch-Janys; Jenny Chang-Claude
Journal:  Breast Cancer Res       Date:  2008-04-17       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.